Uncategorized
OUR Most Recent Insight
Orphan Disease Marketing: Hyper-Targeted Micro-Engagement
2018 was a ground-breaking year for orphan disease with the FDA approving a record 34 new therapies for rare populations. Clearly, the steps laid out
Uncategorized
Orphan Disease Marketing: Hyper-Targeted Micro-Engagement
2018 was a ground-breaking year for orphan disease with the FDA approving a record 34 new therapies for rare populations. Clearly, the steps laid out
Audience Segmentation
What Could Go Wrong This Planning Season?
A simple roadmap for designing a successful campaign
Brand Awareness
People, Pages and Places: 3 Pillars of Patient and Professional Placements
Pondering the proper place of programmatic for pinpoint promotional planning
Media Innovation
Predictive Analytics Removes Guesswork for Pharma Marketers
Improve ROI, cut marketing costs and deliver more effective campaigns
Uncategorized
Come Together
Is HCP/Patient Data Convergence the Holy Grail of Digital Pharma Marketing?
Uncategorized
Rules of the Code
Should Pharma Site Metadata Play by the Same Rules as Paid Search Ads?
Uncategorized
